Table 4 Clinical characters of CRC patients recruited in this study.

From: Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer

Group

Case

Percentage

Gender

 Male

157

56.27%

 Female

122

43.73%

Age

 <60

106

37.99%

 ≥60

173

62.01%

Tumor Location

 Colon

78

27.96%

 Rectum

201

72.04%

Tumor Type

 Ulcerative adenocarcinoma

191

68.46%

 Uplift type adenocarcinoma

56

20.07%

 Ulcerative mucinous adenocarcinoma

4

1.43%

 Uplift mucinous adenocarcinoma

3

1.08%

 Diffuse adenocarcinoma

1

0.36%

 Invasive adenocarcinoma

2

0.72%

Tan umbrella-shaped adenocarcinoma

1

0.36%

 Tubular adenoma carcinogenesis

15

5.38

 Other

6

2.15%

Degree of Differentiation

 Poorly differentiation

35

12.54%

 Moderately differentiation

236

84.59%

 Highly differentiation

8

2.87%

Lymph Node Metastasis

 Yes

103

36.92%

 No

176

63.08%

Vascular Invasion

 Yes

18

6.45%

 No

261

93.55%

Nerve Infiltration

 Yes

15

5.38%

 No

264

94.62%

pTNM Staging

 Stage I

51

18.28%

 Stage II

117

41.94%

 Stage III

96

34.41%

 Stage IV

15

5.38%